| Project Acronym | EASI-OMICS |
|---|---|
| Funding Programme | Horizon Europe |
| Budget | €4,998,257.00 |
| Coordinator | CNAG – Consorcio para la Explotación del Centro Nacional de Análisis Genómico |
| Project Duration | 1 November 2026 – 31 October 2030 |
EASI-OMICS: Integrated Multi-Omics Services for Next Generation Biomedical Research will support biomedical researchers across Europe by providing access to cutting-edge multi-omics technologies and integrated analyses. The project responds to key barriers in the field, including disciplinary silos, rapid technological change, complex data integration, high costs, and unequal access to advanced omics infrastructures.
Through a centralised Transnational Access framework, EASI-OMICS will launch three competitive open calls and support at least 50 ambitious biomedical research projects. These projects will use complementary omics technologies across areas such as disease mechanisms, biomarker discovery and validation, drug response, and clinical translation.
The project will also train researchers in data management, metadata standards, integrative analysis, and innovation, while establishing a FAIR-compliant framework for managing and integrating multi-omics datasets. By combining genomics, transcriptomics, epigenomics, proteomics, bioinformatics, and translational medicine expertise, EASI-OMICS aims to place Europe at the forefront of biomedical multi-omics research and innovation.
Consortium
The EASI-OMICS consortium brings together seven partners from Spain, Sweden, Belgium, and the Netherlands. The consortium is coordinated by CNAG and includes KTH, Uppsala University, KU Leuven, Utrecht University, CRG, and EATRIS ERIC.
Together, these partners represent leading European expertise in genomics, proteomics, bioinformatics, multi-omics analysis, and translational medicine. The consortium builds on the legacy of major European infrastructure projects such as EASI-Genomics and EPIC-XS, combining advanced service provision, data analysis capacity, training, and translational support into one coordinated access framework.
EATRIS’ role in the project
EATRIS leads WP2 – Access provision framework, which runs throughout the full 48-month project. EATRIS’ role is focused on TNA access management, supporting the centralised and transparent framework through which researchers will apply for and access EASI-OMICS services.
EATRIS contributes to user access coordination, project intake and support, service navigation, translational guidance, and innovation-oriented advice. EATRIS also supports the connection between multi-omics outputs and potential clinical or biomedical applications, helping ensure that discoveries generated through the project can move closer to patient benefit.